US Patent Issued to SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE on Aug. 26 for "Nanomolar peptides and derivatives to differentially modulate ephrin receptors" (California Inventor)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,179, issued on Aug. 26, was assigned to SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (La Jolla, Calif.).

"Nanomolar peptides and derivatives to differentially modulate ephrin receptors" was invented by Elena B. Pasquale (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods and compositions engineered to modulate EphA2, including novel peptides with unexpectedly high specificity and binding affinity. The compositions described herein can be attenuated to treat subjects suffering from diseases and/or conditions."

The patent was filed on March 13, 2020, under Application No. 17/438,824.

*For further information,...